Chimeric vaccines
Details for Australian Patent Application No. 2002307145 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): 60/281,608 05.04.01 US; 60/281,607 05.04.01 US; 60/281,621 05.04.01 US
10 April 2003 Application Open to Public Inspection
Published as AU-B-2002307145
29 November 2007 Application Accepted
Published as AU-B-2002307145
3 April 2008 Standard Patent Sealed
30 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
7 January 2010 Section 223 Application Received
The John Hopkins University An application to extend the time from 05 Apr 2008 to 05 Dec 2009 in which to pay a renewal fee has been filed . Address for service in Australia - PIZZEYS Level 14, ANZ Centre 324 Queen Street Brisbane QLD 4000 2003
25 February 2010 Section 223 Application Allowed
The John Hopkins University the time in which to pay a renewal fee has been extended to 05 Dec 2009. Address for service in Australia - PIZZEYS Level 14, ANZ Centre 324 Queen Street Brisbane QLD 4000 2003
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002307146-AlphaNuBeta3 integrin-binding polypeptide monobodies and their use
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser